Citations (178)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Miao-miao Han, Yi-Kai Fan, Yun Zhang & Zheng-qi Dong. (2024) Advances in herbal polysaccharides-based nano-drug delivery systems for cancer immunotherapy. Journal of Drug Targeting 32:3, pages 311-324.
Read now
Read now
Neha Verma & Ashu Bhan Tiku. (2022) Role of mTOR pathway in modulation of radiation induced bystander effects. International Journal of Radiation Biology 98:2, pages 173-182.
Read now
Read now
Kim Cao, Louisa Abbassi, Emanuela Romano & Youlia Kirova. (2021) Radiation therapy and immunotherapy in breast cancer treatment: preliminary data and perspectives. Expert Review of Anticancer Therapy 21:5, pages 501-510.
Read now
Read now
Di Wang, Xia Zhang, Yajie Gao, Xiaonan Cui, Yanqin Yang, Weifeng Mao, Minghuan Li, Bin Zhang & Jinming Yu. (2020) Research Progress and Existing Problems for Abscopal Effect. Cancer Management and Research 12, pages 6695-6706.
Read now
Read now
Lingdi Zhao, Yonghao Yang, Wei Li, Tiepeng Li, Lu Han, Hongwei Lin & Quanli Gao. (2019) Pseudoprogression: an indicator for cure in combined immunotherapy?. Immunotherapy 11:13, pages 1087-1093.
Read now
Read now
Roland Wunderlich, Paul Friedrich Rühle, Lisa Deloch, Franz Rödel, Rainer Fietkau, Udo S. Gaipl & Benjamin Frey. (2019) Ionizing radiation reduces the capacity of activated macrophages to induce T-cell proliferation, but does not trigger dendritic cell-mediated non-targeted effects. International Journal of Radiation Biology 95:1, pages 33-43.
Read now
Read now
Nicolle H. Rekers, Veronica Olivo Pimentel, Ala Yaromina, Natasja G. Lieuwes, Rianne Biemans, Catharina M. L. Zegers, Wilfred T. V. Germeraad, Evert J. Van Limbergen, Dario Neri, Ludwig J. Dubois & Philippe Lambin. (2018) The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses. OncoImmunology 7:4.
Read now
Read now
Henry WC Leung, Shyh-Yau Wang, Huang Jin-Jhih & Agnes LF Chan. (2018) Abscopal effect of radiation on bone metastases of breast cancer: A case report. Cancer Biology & Therapy 19:1, pages 20-24.
Read now
Read now
Margaret E. Gatti-Mays, Jason M. Redman, Julie M. Collins & Marijo Bilusic. (2017) Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations. Human Vaccines & Immunotherapeutics 13:11, pages 2561-2574.
Read now
Read now
Slavisa Tubin & Wolfgang Raunik. (2017) Hunting for abscopal and bystander effects: clinical exploitation of non-targeted effects induced by partial high-single-dose irradiation of the hypoxic tumour segment in oligometastatic patients. Acta Oncologica 56:10, pages 1333-1339.
Read now
Read now
Mieke Van de Walle, Jan Demol, Lorenzo Staelens & Sylvie Rottey. (2017) Abscopal effect in metastatic renal cell carcinoma. Acta Clinica Belgica 72:4, pages 245-249.
Read now
Read now
Franziska Eckert, Ivan Jelas, Moritz Oehme, Stephan M. Huber, Katja Sonntag, Christian Welker, Stephen D. Gillies, Wolfgang Strittmatter, Daniel Zips, Rupert Handgretinger & Karin Schilbach. (2017) Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo. OncoImmunology 6:6.
Read now
Read now
Christian Baues, Maike Trommer-Nestler, Karolina Jablonska, Paul J Bröckelmann, Max Schlaak, Michael von Bergwelt-Baildon, Andreas Engert, Robert Semrau, Simone Marnitz & Sebastian Theurich. (2017) Short Review of Potential Synergies of Immune Checkpoint Inhibition and Radiotherapy with a Focus on Hodgkin Lymphoma: Radio-Immunotherapy Opens New Doors. Immunotherapy 9:5, pages 423-433.
Read now
Read now
Katrien De Wolf, Karim Vermaelen, Gert De Meerleer, Bart N Lambrecht & Piet Ost. (2015) The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy. OncoImmunology 4:10.
Read now
Read now
Jasmin Loh, Ian D Davis, Jarad M Martin & Shankar Siva. (2014) Extracranial Oligometastatic Renal Cell Carcinoma: Current Management and Future Directions. Future Oncology 10:5, pages 761-774.
Read now
Read now
Sandra Demaria & Silvia C. Formenti. (2007) Sensors of ionizing radiation effects on the immunological microenvironment of cancer. International Journal of Radiation Biology 83:11-12, pages 819-825.
Read now
Read now
Cai Grau, Morten Høyer, Jacob Lindegaard & Jens Overgaard. (2006) The emerging evidence for Stereotactic Body Radiotherapy. Acta Oncologica 45:7, pages 771-774.
Read now
Read now
Articles from other publishers (161)
Kejia Wu, Guozhu Zhang, Changbing Shen, Li Zhu, Chongyuan Yu, Kurt Sartorius, Wei Ding, Yong Jiang & Yunjie Lu. (2024) Role of T cells in liver metastasis. Cell Death & Disease 15:5.
Crossref
Crossref
Ryo Yano, Masashi Hirooka, Makoto Morita, Yuki Okazaki, Yoshiko Nakamura, Yusuke Imai, Takao Watanabe, Yohei Koizumi, Osamu Yoshida, Yoshio Tokumoto, Masanori Abe & Yoichi Hiasa. (2024) Hepatocellular Carcinoma Showing Tumor Shrinkage Due to an Abscopal Effect. Internal Medicine 63:2, pages 241-246.
Crossref
Crossref
锐 舒. (2024) Research Progress on Enhancing the Abscopal Effect through the Combination of Radiation and Immunotherapy. Advances in Clinical Medicine 14:03, pages 1824-1830.
Crossref
Crossref
Jonathan E. Leeman. (2023) Role of Radiation in Treatment of Renal Cell Carcinoma. Hematology/Oncology Clinics of North America 37:5, pages 921-924.
Crossref
Crossref
Lina Zhang, Tiantian Tang, Lei Liu, Chunxiao Li, Yuntao Li & Cuizhi Geng. (2023) Effect of tumor-infiltrating lymphocytes depending on the presence of postmastectomy radiotherapy on the prognosis in pT1-2N1M0 breast cancer. Frontiers in Oncology 13.
Crossref
Crossref
Naoya Kemmotsu, Li Zhu, Joji Nagasaki, Yoshihiro Otani, Youki Ueda, Hiromichi Dansako, Yue Fang, Isao Date & Yosuke Togashi. (2023) Combination therapy with hydrogen peroxide and irradiation promotes an abscopal effect in mouse models. Cancer Science.
Crossref
Crossref
Blessie Elizabeth Nelson, Jacob J. Adashek, Aakash Akshay Sheth & Vivek Subbiah. (2023) Predicting the Abscopal Effect: Associated Tumor Histologic Subtypes and Biomarkers. Molecular Cancer Therapeutics 22:6, pages 706-716.
Crossref
Crossref
Camil Ciprian Mireștean, Roxana Irina Iancu & Dragoș Teodor Iancu. (2023) Radiotherapy and Immunotherapy—A Future Partnership towards a New Standard. Applied Sciences 13:9, pages 5643.
Crossref
Crossref
Kendrick Yim & Jonathan E. Leeman. (2023) Radiation Therapy in the Treatment of Localized and Advanced Renal Cancer. Urologic Clinics of North America 50:2, pages 325-334.
Crossref
Crossref
Makiko Sasaki, Mamoru Tanaka, Yuki Kojima, Hirotada Nishie, Takaya Shimura, Eiji Kubota & Hiromi Kataoka. (2023) Anti-tumor immunity enhancement by photodynamic therapy with talaporfin sodium and anti-programmed death 1 antibody. Molecular Therapy - Oncolytics 28, pages 118-131.
Crossref
Crossref
E. Carrasco-Esteban, P. Barrionuevo-Castillo, J. Domínguez-Rullán, M.A. Gómez-Aparicio, M. Ferri-Molina, P. Sáez-Bueno, Z. Zalabarría-Zarrabeitia, M. Scorsetti, S. Arcangeli, F. López-Campos & F. Couñago. (2023) Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?. Clinical Oncology 35:3, pages 163-176.
Crossref
Crossref
Hui Guan, Ziqi Zhou, Xiaorong Hou, Fuquan Zhang, Jing Zhao & Ke Hu. (2022) Safety and potential increased risk of toxicity of radiotherapy combined immunotherapy strategy. Asia-Pacific Journal of Clinical Oncology 19:1, pages 35-50.
Crossref
Crossref
Mai Anh Huynh, Chad Tang, Shankar Siva, Alejandro Berlin, Raquibul Hannan, Andrew Warner, Bridget Koontz, Gert De Meeleer, David Palma, Piet Ost & Phuoc T. Tran. (2023) Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary Cancers. European Urology Oncology 6:1, pages 28-38.
Crossref
Crossref
Hiroshi Onishi. 2023. Stereotactic Body Radiation Therapy. Stereotactic Body Radiation Therapy
171
181
.
Udo S. Gaipl, Anca L. Grosu, Benjamin Frey, Michael Rückert, Henning Schäfer & Ilinca Popp. 2020. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie
1
20
.
Е. А. Степанович, П. Д. Демешко, С. Л. Поляков & И. И. Минайло. (2022) Стереотаксическая лучевая терапия при почечно-клеточном раке. Опыт и непосредственные результаты. Malignant tumours 12:3s1, pages 57-61.
Crossref
Crossref
Edward Nabrinsky, Jason Macklis & Jacob Bitran. (2022) A Review of the Abscopal Effect in the Era of Immunotherapy. Cureus.
Crossref
Crossref
Mihailo Miljanic, Steven Montalvo, Maureen Aliru, Tidie Song, Maria Leon-Camarena, Kevin Innella, Dragan Vujovic, Ritsuko Komaki & Puneeth Iyengar. (2022) The Evolving Interplay of SBRT and the Immune System, along with Future Directions in the Field. Cancers 14:18, pages 4530.
Crossref
Crossref
Tahir Bashir Dar, Fleury Augustin Nsole Biteghe, Ruchi Kakar-Bhanot, Eric Chekwebe Aniogo, Zaria Malindi, Olusiji Alex Akinrinmade, Nyangone Ekome Toung Chalomie, Arnaud John Kombe Kombe, Sophie Aboughe Angone, Jean Marc Ngome Ndong & Jean Delacroix Ndong. (2022) Synergistic effects of radiotherapy and targeted immunotherapy in improving tumor treatment efficacy: a review. Clinical and Translational Oncology 24:12, pages 2255-2271.
Crossref
Crossref
Mark Mikhail, Kevin J. Chua, Labeeqa Khizir, Alexandra Tabakin & Eric A. Singer. (2022) Role of metastasectomy in the management of renal cell carcinoma. Frontiers in Surgery 9.
Crossref
Crossref
Shohei Katsuki, Yutaka Takahashi, Keisuke Tamari, Kazumasa Minami, Wataru Takenaka, Yoriko Ibuki, Junya Yamamoto, Shotaro Tatekawa, Kazuhiko Hayashi, Yuji Seo, Fumiaki Isohashi, Kazuhiko Ogawa & Masahiko Koizumi. (2022) Radiation therapy enhances systemic antitumor efficacy in PD-L1 therapy regardless of sequence of radiation in murine osteosarcoma. PLOS ONE 17:7, pages e0271205.
Crossref
Crossref
Yi Chen, Hongqing Zhuang & Junjie Wang. (2020) The rationale and toxicity of combined cranial radiotherapy and immune checkpoint inhibitors in non‐small cell lung cancer. Asia-Pacific Journal of Clinical Oncology 18:3, pages 165-170.
Crossref
Crossref
Steven J. HattenJrJr, Eric J. Lehrer, Jenn Liao, Congzhou M. Sha, Daniel M. Trifiletti, Shankar Siva, Sean M. McBride, David Palma, Sheldon L. Holder & Nicholas G. Zaorsky. (2022) A Patient-Level Data Meta-analysis of the Abscopal Effect. Advances in Radiation Oncology 7:3, pages 100909.
Crossref
Crossref
Sophia C. Kamran & Xin Gao. (2022) Solving the Stereotactic Body Radiotherapy and Checkpoint Inhibitor Puzzle in Metastatic Renal Cell Carcinoma. European Urology 81:3, pages 283-284.
Crossref
Crossref
Milan Vošmik, Mustafa Aml Banni & Libor Hruška. (2022) The role of radiotherapy in renal cell carcinoma and the potential of its combination with immunotherapy. Onkologie 16:1, pages 16-19.
Crossref
Crossref
Myriam Ben Khelil, Yann Godet, Syrine Abdeljaoued, Christophe Borg, Olivier Adotévi & Romain Loyon. (2022) Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy. Cancers 14:1, pages 260.
Crossref
Crossref
Rupen Desai, Andrew T. Coxon & Gavin P. Dunn. (2022) Therapeutic applications of the cancer immunoediting hypothesis. Seminars in Cancer Biology 78, pages 63-77.
Crossref
Crossref
Alina M. Pevzner, Matvey M. Tsyganov, Marina K. Ibragimova & Nikolai V. Litvyakov. (2021) Abscopal effect in the radio and immunotherapy. Radiation Oncology Journal 39:4, pages 247-253.
Crossref
Crossref
Mateusz Bilski, Paulina Mertowska, Sebastian Mertowski, Marcin Sawicki, Anna Hymos, Paulina Niedźwiedzka-Rystwej & Ewelina Grywalska. (2021) The Role of Conventionally Fractionated Radiotherapy and Stereotactic Radiotherapy in the Treatment of Carcinoid Tumors and Large-Cell Neuroendocrine Cancer of the Lung. Cancers 14:1, pages 177.
Crossref
Crossref
Baljeet Seniwal, Velaphi C. Thipe, Sukhvir Singh, Telma C. F. Fonseca & Lucas Freitas de Freitas. (2021) Recent Advances in Brachytherapy Using Radioactive Nanoparticles: An Alternative to Seed-Based Brachytherapy. Frontiers in Oncology 11.
Crossref
Crossref
Barbara Link, Adriana Torres Crigna, Michael Hölzel, Frank A. Giordano & Olga Golubnitschaja. (2021) Abscopal Effects in Metastatic Cancer: Is a Predictive Approach Possible to Improve Individual Outcomes?. Journal of Clinical Medicine 10:21, pages 5124.
Crossref
Crossref
James R. Janopaul-Naylor, Yang Shen, David C. Qian & Zachary S. Buchwald. (2021) The Abscopal Effect: A Review of Pre-Clinical and Clinical Advances. International Journal of Molecular Sciences 22:20, pages 11061.
Crossref
Crossref
Vitaly Margulis, Yuval Freifeld, Laurentiu M. Pop, Subrata Manna, Payal Kapur, Ivan Pedrosa, Alana Christie, Osama Mohamad, Samantha Mannala, Nirmish Singla, Michael Wait, Aditya Bagrodia, Solomon L. Woldu, Jeffrey Gahan, James Brugarolas, Robert Timmerman & Raquibul Hannan. (2021) Neoadjuvant SABR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus—Safety Lead-in Results of a Phase 2 Trial. International Journal of Radiation Oncology*Biology*Physics 110:4, pages 1135-1142.
Crossref
Crossref
Jason A. Mouabbi, Momal Chand, Ishaq A. Asghar, Ramen Sakhi, Daniel Ockner, Carrie L. Dul, Tarik Hadid, Amr Aref, Mothaffar F. Rimawi & Valentina Hoyos. (2021) Lumpectomy followed by radiation improves survival in HER2 positive and triple‐negative breast cancer with high tumor‐infiltrating lymphocytes compared to mastectomy alone. Cancer Medicine 10:14, pages 4790-4795.
Crossref
Crossref
Anthony T. Nguyen, Stephen L. Shiao & Heather L. McArthur. (2021) Advances in Combining Radiation and Immunotherapy in Breast Cancer. Clinical Breast Cancer 21:2, pages 143-152.
Crossref
Crossref
Pu Zhou, Diangang Chen, Bo Zhu, Wei Chen, Qichao Xie, Yali Wang, Qiulin Tan, Bibo Yuan, Xuejiao Zuo, Changlin Huang, Hongfan Zhu & Guanghui Li. (2021) Stereotactic Body Radiotherapy Is Effective in Modifying the Tumor Genome and Tumor Immune Microenvironment in Non-Small Cell Lung Cancer or Lung Metastatic Carcinoma. Frontiers in Immunology 11.
Crossref
Crossref
Amanda J. Oliver, Phillip K. Darcy, Joseph A. Trapani, Michael H. Kershaw & Clare Y. Slaney. (2020) Cross‐talk between tumors at anatomically distinct sites. The FEBS Journal 288:1, pages 81-90.
Crossref
Crossref
Vishesh Agrawal, Kimberly Thomas Benjamin & Eric C. Ko. (2020) Radiotherapy and Immunotherapy Combinations for Lung Cancer. Current Oncology Reports 23:1.
Crossref
Crossref
John W. Myers, George E. Peoples & Guy T. Clifton. 2021. Cancer Immunology. Cancer Immunology
85
128
.
Junko Takahashi & Shinsuke Nagasawa. (2020) Immunostimulatory Effects of Radiotherapy for Local and Systemic Control of Melanoma: A Review. International Journal of Molecular Sciences 21:23, pages 9324.
Crossref
Crossref
Veronica Mollica, Matteo Santoni, Vincenzo Di Nunno, Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Nicola Battelli, Rodolfo Montironi & Francesco Massari. (2020) Immunotherapy and Radiation Therapy in Renal Cell Carcinoma. Current Drug Targets 21:14, pages 1463-1475.
Crossref
Crossref
Dengbo Ji, Can Song, Yongheng Li, Jinhong Xia, Yanjing Wu, Jinying Jia, Xinxin Cui, Songmao Yu & Jin Gu. (2020) Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer. Journal for ImmunoTherapy of Cancer 8:2, pages e000826.
Crossref
Crossref
Maria Ochoa de Olza, Jean Bourhis, Melita Irving, George Coukos & Fernanda G Herrera. (2020) High versus low dose irradiation for tumor immune reprogramming. Current Opinion in Biotechnology 65, pages 268-283.
Crossref
Crossref
Jacky Chow, Nicholas C. HoffendScott I. Abrams, Thomas Schwaab, Anurag K. Singh & Jason B. Muhitch. (2020) Radiation induces dynamic changes to the T cell repertoire in renal cell carcinoma patients. Proceedings of the National Academy of Sciences 117:38, pages 23721-23729.
Crossref
Crossref
Takahiro Kojima. (2020) Editorial Comment from Dr Kojima to Possible abscopal effect after discontinuation of nivolumab in metastatic renal cell carcinoma. IJU Case Reports 3:5, pages 219-219.
Crossref
Crossref
Xiaohan Zhou, Wanting Hou, Ling Gao, Lin Shui, Cheng Yi & Hong Zhu. (2020) Synergies of Antiangiogenic Therapy and Immune Checkpoint Blockade in Renal Cell Carcinoma: From Theoretical Background to Clinical Reality. Frontiers in Oncology 10.
Crossref
Crossref
Dominic C. Grimberg, Ankeet Shah & Brant A. Inman. (2020) Overview of Taris GemRIS, a Novel Drug Delivery System for Bladder Cancer. European Urology Focus 6:4, pages 620-622.
Crossref
Crossref
Li-jun Liang, Chen-xi Hu, Yi-xuan Wen, Xiao-wei Geng, Ting Chen, Guo-qing Gu, Lei Wang, You-you Xia, Yong Liu, Jia-yan Fei, Jie Dong, Feng-hua Zhao, Yiliyar Ahongjiang, Kai-yuan Hui & Xiao-dong Jiang. (2020) Apatinib Combined with Local Irradiation Leads to Systemic Tumor Control via Reversal of Immunosuppressive Tumor Microenvironment in Lung Cancer. Cancer Research and Treatment 52:2, pages 406-418.
Crossref
Crossref
Andrew Brandmaier & Silvia C. Formenti. (2020) The Impact of Radiation Therapy on Innate and Adaptive Tumor Immunity. Seminars in Radiation Oncology 30:2, pages 139-144.
Crossref
Crossref
Ilaria Maggio, Lisa Manuzzi, Giuseppe Lamberti, Angela Dalia Ricci, Nastassja Tober & Davide Campana. (2020) Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia. Cancers 12:4, pages 832.
Crossref
Crossref
Wenxin Xu, Michael B. Atkins & David F. McDermott. (2020) Checkpoint inhibitor immunotherapy in kidney cancer. Nature Reviews Urology 17:3, pages 137-150.
Crossref
Crossref
Michael Timaner, Ruslana Kotsofruk, Ziv Raviv, Ksenia Magidey, Dvir Shechter, Tal Kan, Alexander Nevelsky, Shahar Daniel, Elisabeth G. E. de Vries, Tongwu Zhang, Orit Kaidar-Person, Robert S. Kerbel & Yuval Shaked. (2019) Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1. Oncogene 39:1, pages 187-203.
Crossref
Crossref
Andrew G. Brandmaier, Rohan Ramakrishna & Silvia C. Formenti. 2020. Central Nervous System Metastases. Central Nervous System Metastases
355
369
.
N. V. Dengina, T. Mitin, S. V. Gamayunov, S. Safina, Yu. M. Kreinina & I. V. Tsimafeyeu. (2019) Phase 1b multicenter study of the safety and efficacy of stereotactic body radiation therapy for extracranial renal cell carcinoma metastases in combination with tyrosine kinase inhibitors or checkpoint inhibitors (VOLGA STUDY).. Malignant tumours 9:3, pages 57-64.
Crossref
Crossref
Alexandros Papachristofilou, Madeleine M. Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Christian Weiss, Miklos Pless, Richard Cathomas, Wolfgang Hilbe, Georg Pall, Thomas Wehler, Jürgen Alt, Helge Bischoff, Michael Geißler, Frank Griesinger, Karl-Josef Kallen, Mariola Fotin-Mleczek, Andreas Schröder, Birgit Scheel, Anke Muth, Tobias Seibel, Claudia Stosnach, Fatma Doener, Henoch S. Hong, Sven D. Koch, Ulrike Gnad-Vogt & Alfred Zippelius. (2019) Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Guibin Pang, Chao Chen, Yun Liu, Tianyan Jiang, Huan Yu, Yanxian Wu, Yangyun Wang, Fu-Jun Wang, Zhiyong Liu & Leshuai W. Zhang. (2019) Bioactive Polysaccharide Nanoparticles Improve Radiation-Induced Abscopal Effect through Manipulation of Dendritic Cells. ACS Applied Materials & Interfaces 11:45, pages 42661-42670.
Crossref
Crossref
Junling Zhang, Dan Yao, Yimeng Song, Yan Pan, Lin Zhu, Yang Bai, Yanwu Xu, Jianghong Zhang & Chunlin Shao. (2019) Fractionated irradiation of right thorax induces abscopal damage on testes leading to decline in fertility. Scientific Reports 9:1.
Crossref
Crossref
Tatsuya Nagano, Motoko Tachihara & Yoshihiro Nishimura. (2019) Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer. Current Cancer Drug Targets 19:8, pages 595-630.
Crossref
Crossref
Alexander Rühle, Nicolaus Andratschke, Shankar Siva & Matthias Guckenberger. (2019) Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?. Clinical and Translational Radiation Oncology 18, pages 104-112.
Crossref
Crossref
Goto. (2019) Radiation as an In Situ Auto-Vaccination: Current Perspectives and Challenges. Vaccines 7:3, pages 100.
Crossref
Crossref
Mark A. D’Andrea & G. Kesava Reddy. (2019) The systemic immunostimulatory effects of radiation therapy producing overall tumor control through the abscopal effect. Journal of Radiation Oncology 8:2, pages 143-156.
Crossref
Crossref
Anikó Kovács, Axel Stenmark Tullberg, Elisabeth Werner Rönnerman, Erik Holmberg, Linda Hartman, Martin Sjöström, Dan Lundstedt, Per Malmström, Mårten Fernö & Per Karlsson. (2019) Effect of Radiotherapy After Breast-Conserving Surgery Depending on the Presence of Tumor-Infiltrating Lymphocytes: A Long-Term Follow-Up of the SweBCG91RT Randomized Trial. Journal of Clinical Oncology 37:14, pages 1179-1187.
Crossref
Crossref
Simone de Leve, Florian Wirsdörfer & Verena Jendrossek. (2019) Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy. Frontiers in Immunology 10.
Crossref
Crossref
Shuji Kojima, Jerry M. Cuttler, Kiyomi Inoguchi, Kenshou Yorozu, Takashisa Horii, Noriko Shimura, Hironobu Koga & Akihisa Murata. (2019) Radon Therapy Is Very Promising as a Primary or an Adjuvant Treatment for Different Types of Cancers: 4 Case Reports. Dose-Response 17:2, pages 155932581985316.
Crossref
Crossref
Harpaul S. Gill & Suresh S. Ramalingam. (2019) A new standard of care for patients with surgically unresectable stage III non‐small cell lung cancer. Cancer.
Crossref
Crossref
Natalia Dengina, Timur Mitin, Sergey Gamayunov, Sufia Safina, Yuliya Kreinina & Ilya Tsimafeyeu. (2019) Stereotactic body radiation therapy in combination with systemic therapy for metastatic renal cell carcinoma: a prospective multicentre study. ESMO Open 4:5, pages e000535.
Crossref
Crossref
Hak Choy & Jameson Travis Mendel. 2019. Pulmonary Adenocarcinoma: Approaches to Treatment. Pulmonary Adenocarcinoma: Approaches to Treatment
57
86
.
Laura-Maria Krabbe, Solomon L. Woldu, Oner Sanli & Vitaly Margulis. 2019. Urologic Oncology. Urologic Oncology
615
640
.
Christopher Wilke, L. Chinsoo Cho & Paul W. Sperduto. 2019. Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy. Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy
347
357
.
Dawei Chen, Xinyu Song, Haiyong Wang, Zhenwu Gao, Wenjuan Meng, Shuquan Chen, Yunfeng Ma, Youda Wang, Kong Li, Jinming Yu & Jinbo Yue. (2018) Previous Radiotherapy Increases the Efficacy of IL-2 in Malignant Pleural Effusion: Potential Evidence of a Radio-Memory Effect?. Frontiers in Immunology 9.
Crossref
Crossref
Hanne Locy, Sven de Mey, Wout de Mey, Mark De Ridder, Kris Thielemans & Sarah K. Maenhout. (2018) Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend. Frontiers in Immunology 9.
Crossref
Crossref
Arturo Navarro-Martín, Isabel Galiana, Miguel Berenguer Frances, Jon Cacicedo, Rut Cañas Cortés, Silvia Comas Anton, Susana Padrones Sánchez, Santiago Bolívar Cuevas, Renate Parry & Ferran Guedea Edo. (2018) Preliminary Study of the Effect of Stereotactic Body Radiotherapy (SBRT) on the Immune System in Lung Cancer Patients Unfit for Surgery: Immunophenotyping Analysis. International Journal of Molecular Sciences 19:12, pages 3963.
Crossref
Crossref
Rohann J. M. Correa, Belal Ahmad, Andrew Warner, Craig Johnson, Mary J. MacKenzie, Stephen E. Pautler, Glenn S. Bauman, George B. Rodrigues & Alexander V. Louie. (2018) A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma. Radiation Oncology 13:1.
Crossref
Crossref
Irene Moya Horno, Santiago Viteri, Pablo Rubinstein, José Maestre, Arnaldo Alvarado, Inessa Koptseva, Sara Simonetti, Natalia Lugo, José Luis Cisneros & Rafael Rosell. (2018) Anti-Programmed Death Receptor 1 Signalling Immunotherapy as a Part of Curative Intent Strategies for Stages I-III Non-Small Cell Lung Cancer. EMJ Respiratory, pages 109-116.
Crossref
Crossref
Joseph Kattan, Elie El Rassy, Tarek Assi, Ziad Bakouny & Nicholas Pavlidis. (2018) A comprehensive review of the role of immune checkpoint inhibitors in brain metastasis of renal cell carcinoma origin. Critical Reviews in Oncology/Hematology 130, pages 60-69.
Crossref
Crossref
Eric C. Ko, Kimberly Thomas Benjamin & Silvia C. Formenti. (2018) Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionation. Advances in Radiation Oncology 3:4, pages 486-493.
Crossref
Crossref
Rohann J.M. Correa, George B. Rodrigues, Hanbo Chen, Andrew Warner, Belal Ahmad & Alexander V. Louie. (2018) Stereotactic Ablative Radiotherapy (SABR) for Large Renal Tumors. American Journal of Clinical Oncology 41:6, pages 568-575.
Crossref
Crossref
Catherine A. Pembroke, Bernard Fortin & Neil Kopek. (2018) Comparison of survival and prognostic factors in patients treated with stereotactic body radiotherapy for oligometastases or oligoprogression. Radiotherapy and Oncology 127:3, pages 493-500.
Crossref
Crossref
Wilfred Ngwa, Omoruyi Credit Irabor, Jonathan D. Schoenfeld, Jürgen Hesser, Sandra Demaria & Silvia C. Formenti. (2018) Using immunotherapy to boost the abscopal effect. Nature Reviews Cancer 18:5, pages 313-322.
Crossref
Crossref
Jie Lan, Rui Li, Li-Mei Yin, Lei Deng, Jun Gui, Bao-Qing Chen, Lin Zhou, Mao-Bin Meng, Qiao-Rong Huang, Xian-Ming Mo, Yu-Quan Wei, Bo Lu, Adam Dicker, Jian-Xin Xue & You Lu. (2018) Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 101:1, pages 74-87.
Crossref
Crossref
Zuzana Hlavata, Cinzia Solinas, Pushpamali De Silva, Michele Porcu, Luca Saba, Karen Willard-Gallo & Mario Scartozzi. (2018) The Abscopal Effect in the Era of Cancer Immunotherapy: a Spontaneous Synergism Boosting Anti-tumor Immunity?. Targeted Oncology 13:2, pages 113-123.
Crossref
Crossref
Annelies Verbiest, Gert De Meerleer, Maarten Albersen & Benoit Beuselinck. (2018) Non-Surgical Ablative Treatment of Distant Extracranial Metastases for Renal Cell Carcinoma: A Systematic Review. Kidney Cancer 2:1, pages 57-67.
Crossref
Crossref
Emily Kim & Stefan Zschiedrich. (2018) Renal Cell Carcinoma in von Hippel–Lindau Disease—From Tumor Genetics to Novel Therapeutic Strategies. Frontiers in Pediatrics 6.
Crossref
Crossref
Kosaku Mimura, Leo Yamada, Daisuke Ujiie, Suguru Hayase, Takeshi Tada, Hiroyuki Hanayama, Aung Kyi Thar Min, Masahiko Shibata, Tomoyuki Momma, Zenichiro Saze, Shinji Ohki & Koji Kono. (2018) Immunotherapy for esophageal squamous cell carcinoma: a review. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE 64:2, pages 46-53.
Crossref
Crossref
Koji Kono, Kousaku Mimura, Reo Yamada, Daisuke Ujiie, Suguru Hayase, Takeshi Tada, Hiroyuki Hanayama, Aung Kyi Thar Min, Masahiko Shibata, Tomoyuki Momma, Zenichirou Saze & Shinji Ohki. (2017) Current status of cancer immunotherapy for esophageal squamous cell carcinoma. Esophagus 15:1, pages 1-9.
Crossref
Crossref
Michael A. Garcia & Alexander R. Gottschalk. 2018. Handbook of Evidence-Based Radiation Oncology. Handbook of Evidence-Based Radiation Oncology
535
543
.
Sandra Demaria, Sophia Bornstein & Silvia C. Formenti. 2018. Oncoimmunology. Oncoimmunology
507
524
.
Nikko Brix, Anna Tiefenthaller, Heike Anders, Claus Belka & Kirsten Lauber. (2017) Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences. Immunological Reviews 280:1, pages 249-279.
Crossref
Crossref
Jang Hee Han, Seung Hwan Lee, Won Sik Ham, Woong Kyu Han, Koon Ho Rha, Young Deuk Choi, Sung Joon Hong & Young Eun Yoon. (2017) Inherent characteristics of metachronous metastatic renal cell carcinoma in the era of targeted agents. Oncotarget 8:45, pages 78825-78837.
Crossref
Crossref
Sameera S. Kumar, Kristin A. Higgins & Ronald C. McGarry. (2017) Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy. Frontiers in Oncology 7.
Crossref
Crossref
Ting Zhang, Haifeng Yu, Chao Ni, Tao Zhang, Luying Liu, Qinghua Lv, Zhigang Zhang, Zhen Wang, Dang Wu, Pin Wu, Guodi Chen, Liancong Wang, Qichun Wei, Jian Huang & Xiaojian Wang. (2017) Hypofractionated stereotactic radiation therapy activates the peripheral immune response in operable stage I non-small-cell lung cancer. Scientific Reports 7:1.
Crossref
Crossref
Gaël Deplanque, Keyvan Shabafrouz & Michel Obeid. (2017) Can local radiotherapy and IL-12 synergise to overcome the immunosuppressive tumor microenvironment and allow “in situ tumor vaccination”?. Cancer Immunology, Immunotherapy 66:7, pages 833-840.
Crossref
Crossref
J.P. Nesseler, D. Peiffert, G. Vogin & P. Nickers. (2017) Cancer, radiothérapie et système immunitaire. Cancer/Radiothérapie 21:4, pages 307-315.
Crossref
Crossref
Enrique Chajon, Joël Castelli, Hugo Marsiglia & Renaud De Crevoisier. (2017) The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership. Critical Reviews in Oncology/Hematology 111, pages 124-132.
Crossref
Crossref
Dan Ishihara, Laurentiu Pop, Tsuguhide Takeshima, Puneeth Iyengar & Raquibul Hannan. (2016) Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment. Cancer Immunology, Immunotherapy 66:3, pages 281-298.
Crossref
Crossref
Jennifer Kalina, David Neilson, Alexandra Comber, Jennifer Rauw, Abraham Alexander, Joanna Vergidis & Julian Lum. (2017) Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy. Cancers 9:12, pages 13.
Crossref
Crossref
Fernanda G. Herrera, Jean Bourhis & George Coukos. (2016) Radiotherapy combination opportunities leveraging immunity for the next oncology practice. CA: A Cancer Journal for Clinicians 67:1, pages 65-85.
Crossref
Crossref
Michael R. Folkert & Robert D. Timmerman. (2017) Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT). Advanced Drug Delivery Reviews 109, pages 3-14.
Crossref
Crossref
Daniel R. Wahl & Theodore S. Lawrence. (2017) Integrating chemoradiation and molecularly targeted therapy. Advanced Drug Delivery Reviews 109, pages 74-83.
Crossref
Crossref
Jeffrey Meyer & Tracey E. Schefter. 2017. Radiation Therapy for Liver Tumors. Radiation Therapy for Liver Tumors
49
55
.
Laura-Maria Krabbe, Solomon L. Woldu, Oner Sanli & Vitaly Margulis. 2018. Urologic Oncology. Urologic Oncology
1
26
.
Gregory S. Alexander, Joshua D. Palmer, Madalina Tuluc, Jianqing Lin, Adam P. Dicker, Voichita Bar-Ad, Larry A Harshyne, Jennifer Louie, Colette M. Shaw, D. Craig Hooper & Bo Lu. (2016) Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy. Journal of Hematology & Oncology 9:1.
Crossref
Crossref
Jacques Bernier. (2016) Immuno-oncology: Allying forces of radio- and immuno-therapy to enhance cancer cell killing. Critical Reviews in Oncology/Hematology 108, pages 97-108.
Crossref
Crossref
Ted K. Yanagihara, Heva J. Saadatmand & Tony J. C. Wang. (2016) Reevaluating stereotactic radiosurgery for glioblastoma: new potential for targeted dose-escalation. Journal of Neuro-Oncology 130:3, pages 397-411.
Crossref
Crossref
Shaveta Mehta, Tim Illidge & Ananya Choudhury. (2016) Immunotherapy with radiotherapy in urological malignancies. Current Opinion in Urology 26:6, pages 514-522.
Crossref
Crossref
Jonathan Khalifa, Arya Amini, Sanjay Popat, Laurie E. Gaspar & Corinne Faivre-Finn. (2016) Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted Therapies. Journal of Thoracic Oncology 11:10, pages 1627-1643.
Crossref
Crossref
Ilinca Popp, Anca Ligia Grosu, Gabriele Niedermann & Dan G. Duda. (2016) Immune modulation by hypofractionated stereotactic radiation therapy: Therapeutic implications. Radiotherapy and Oncology 120:2, pages 185-194.
Crossref
Crossref
Thomas H. P. M. Habets, Tammy Oth, Ans W. Houben, Mirelle J. A. J. Huijskens, Birgit L. M. G. Senden-Gijsbers, Melanie C. A. Schnijderberg, Boudewijn Brans, Ludwig J. Dubois, Philippe Lambin, Marijke De Saint-Hubert, Wilfred T. V. Germeraad, Marcel G. J. Tilanus, Felix M. Mottaghy, Gerard M. J. Bos & Joris Vanderlocht. (2016) Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response. PLOS ONE 11:7, pages e0159515.
Crossref
Crossref
Eric D. Brooks, Jonathan E. Schoenhals, Chad Tang, Goran Micevic, Daniel R. Gomez, Joe Y. Chang & James W. Welsh. (2016) Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid Tumors. The Cancer Journal 22:4, pages 257-266.
Crossref
Crossref
Ying-Chieh Yang & Chi-Shiun Chiang. (2016) Challenges of Using High-Dose Fractionation Radiotherapy in Combination Therapy. Frontiers in Oncology 6.
Crossref
Crossref
Jan T. Poleszczuk, Kimberly A. Luddy, Sotiris Prokopiou, Mark Robertson-Tessi, Eduardo G. Moros, Mayer Fishman, Julie Y. Djeu, Steven E. Finkelstein & Heiko Enderling. (2016) Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions. Cancer Research 76:5, pages 1009-1018.
Crossref
Crossref
Maria Widel. (2016) Radiation Induced Bystander Effect: From <i>in Vitro</i> Studies to Clinical Application. International Journal of Medical Physics, Clinical Engineering and Radiation Oncology 05:01, pages 1-17.
Crossref
Crossref
Yazan Abuodeh, Puja Venkat & Sungjune Kim. (2016) Systematic review of case reports on the abscopal effect. Current Problems in Cancer 40:1, pages 25-37.
Crossref
Crossref
Ying Huang, Wei Chen, Bin S. Teh & E. Brian Butler. (2015) Combining radiotherapy and immunotherapy for prostate cancer: two decades of research from preclinical to clinical trials. Journal of Radiation Oncology 4:4, pages 365-375.
Crossref
Crossref
Dan Ishihara, Puneeth Iyengar, Jeffrey Meyer, Robert Timmerman, Hak Choy & Raquibul Hannan. (2015) The combination of radiation therapy and immunotherapy for genitourinary cancer treatment: rationale, current evidence, and prospects. Journal of Radiation Oncology 4:4, pages 355-363.
Crossref
Crossref
Albert C. Chen, E. Brian Butler, Simon S. Lo & Bin S. Teh. (2015) Radiotherapy and the abscopal effect: insight from the past, present, and future. Journal of Radiation Oncology 4:4, pages 321-330.
Crossref
Crossref
Wen Jiang, Chad Tang & Joe Y. Chang. (2015) Radiation with immunotherapy: an emerging combination for cancer treatment. Journal of Radiation Oncology 4:4, pages 331-338.
Crossref
Crossref
David A. Reardon, Mark R. Gilbert, Wolfgang Wick & Linda Liau. (2015) Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy. Neuro-Oncology 17:suppl 7, pages vii32-vii40.
Crossref
Crossref
Arya Amini, Basel Altoos, Maria T. Bourlon, Edward Bedrick, Shilpa Bhatia, Elizabeth R. Kessler, Thomas W. Flaig, Christine M. Fisher, Brian D. Kavanagh, Elaine T. Lam & Sana D. Karam. (2015) Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?. Practical Radiation Oncology 5:6, pages e589-e596.
Crossref
Crossref
Suresh J. Haikerwal, Jim Hagekyriakou, Michael MacManus, Olga A. Martin & Nicole M. Haynes. (2015) Building immunity to cancer with radiation therapy. Cancer Letters 368:2, pages 198-208.
Crossref
Crossref
Holly E. Barker, James T. E. Paget, Aadil A. Khan & Kevin J. Harrington. (2015) The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nature Reviews Cancer 15:7, pages 409-425.
Crossref
Crossref
Kevin K. H. Chow, Wendy Hara, Michael Lim & Gordon Li. (2015) Combining immunotherapy with radiation for the treatment of glioblastoma. Journal of Neuro-Oncology 123:3, pages 459-464.
Crossref
Crossref
Cheol-Hun Son, Jae-Ho Bae, Dong-Yeok Shin, Hong-Rae Lee, Wol-Soon Jo, Kwangmo Yang & You-Soo Park. (2015) Combination Effect of Regulatory T-Cell Depletion and Ionizing Radiation in Mouse Models of Lung and Colon Cancer. International Journal of Radiation Oncology*Biology*Physics 92:2, pages 390-398.
Crossref
Crossref
Kobe Reynders, Tim Illidge, Shankar Siva, Joe Y. Chang & Dirk De Ruysscher. (2015) The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant. Cancer Treatment Reviews 41:6, pages 503-510.
Crossref
Crossref
Catharina M.L. Zegers, Nicolle H. Rekers, Dana H.F. Quaden, Natasja G. Lieuwes, Ala Yaromina, Wilfred T.V. Germeraad, Lotte Wieten, Erik A.L. Biessen, Louis Boon, Dario Neri, Esther G.C. Troost, Ludwig J. Dubois & Philippe Lambin. (2015) Radiotherapy Combined with the Immunocytokine L19-IL2 Provides Long-lasting Antitumor Effects. Clinical Cancer Research 21:5, pages 1151-1160.
Crossref
Crossref
Derick Okwan-Duodu, Brian P. Pollack, David Lawson & Mohammad K. Khan. (2015) Role of Radiation Therapy as Immune Activator in the Era of Modern Immunotherapy for Metastatic Malignant Melanoma. American Journal of Clinical Oncology 38:1, pages 119-125.
Crossref
Crossref
Encouse B. Golden & Lionel Apetoh. (2015) Radiotherapy and Immunogenic Cell Death. Seminars in Radiation Oncology 25:1, pages 11-17.
Crossref
Crossref
Shankar Siva, Michael P. MacManus, Roger F. Martin & Olga A. Martin. (2015) Abscopal effects of radiation therapy: A clinical review for the radiobiologist. Cancer Letters 356:1, pages 82-90.
Crossref
Crossref
Franz Rödel, Benjamin Frey, Gabriele Multhoff & Udo Gaipl. (2015) Contribution of the immune system to bystander and non-targeted effects of ionizing radiation. Cancer Letters 356:1, pages 105-113.
Crossref
Crossref
Pedro Carlos Lara, Jesús Joaquín López-Peñalver, Virgínea de Araújo Farias, M. Carmen Ruiz-Ruiz, Francisco Javier Oliver & José Mariano Ruiz de Almodóvar. (2015) Direct and bystander radiation effects: A biophysical model and clinical perspectives. Cancer Letters 356:1, pages 5-16.
Crossref
Crossref
B. van Oorschot, B. Polat & D. Rades. (2014) Strahlentherapie beim metastasierten NierenzellkarzinomRadiotherapy of metastasized renal cell carcinoma. Der Onkologe 21:1, pages 50-54.
Crossref
Crossref
Guy T. Clifton, Elizabeth A. Mittendorf & George E. Peoples. 2015. Cancer Immunology. Cancer Immunology
87
129
.
Giuseppe V. Masucci, Luigi De Petris, Andreas Lundqvist, Rolf Kiessling & Rolf Lewensohn. 2015. Developments in T Cell Based Cancer Immunotherapies. Developments in T Cell Based Cancer Immunotherapies
211
229
.
Price Jackson, Farshad Foroudi, Daniel Pham, Michael S Hofman, Nicholas Hardcastle, Jason Callahan, Tomas Kron & Shankar Siva. (2014) Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial 99mTc-DMSA SPECT/CT. Radiation Oncology 9:1.
Crossref
Crossref
Martin Sebastian, Alexandros Papachristofilou, Christian Weiss, Martin Früh, Richard Cathomas, Wolfgang Hilbe, Thomas Wehler, Gerd Rippin, Sven D Koch, Birgit Scheel, Mariola Fotin-Mleczek, Regina Heidenreich, Karl-Josef Kallen, Ulrike Gnad-Vogt & Alfred Zippelius. (2014) Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer. BMC Cancer 14:1.
Crossref
Crossref
Melis Gultekin, Ozan Yazici, Gulnihan Eren, Deniz Yuce, Sercan Aksoy, Yavuz Ozisik, Nilufer Guler, Gozde Yazici, Pervin Hurmuz, Ferah Yildiz, Kadri Altundag & Murat Gurkaynak. (2014) Impact of locoregional treatment on survival in patients presented with metastatic breast carcinoma. The Breast 23:6, pages 775-783.
Crossref
Crossref
Morgan A. O'Brien, Derek G. Power, A. James P. Clover, Brian Bird, Declan M. Soden & Patrick F. Forde. (2014) Local tumour ablative therapies: Opportunities for maximising immune engagement and activation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:2, pages 510-523.
Crossref
Crossref
Ralph E. Vatner, Benjamin T. Cooper, Claire Vanpouille-Box, Sandra Demaria & Silvia C. Formenti. (2014) Combinations of Immunotherapy and Radiation in Cancer Therapy. Frontiers in Oncology 4.
Crossref
Crossref
Patrick Cheung, Isabelle Thibault & Georg A. Bjarnason. (2014) The emerging roles of stereotactic ablative radiotherapy for metastatic renal cell carcinoma. Current Opinion in Supportive & Palliative Care 8:3, pages 258-264.
Crossref
Crossref
Yousef Zakharia, Osama Rahma & Samir N. Khleif. (2014) Ovarian Cancer from an Immune Perspective. Radiation Research 182:2, pages 239-251.
Crossref
Crossref
Mary-Keara Boss, Robert Bristow & Mark W. Dewhirst. (2014) Linking the History of Radiation Biology to the Hallmarks of Cancer. Radiation Research 181:6, pages 561-577.
Crossref
Crossref
Gert De Meerleer, Vincent Khoo, Bernard Escudier, Steven Joniau, Alberto Bossi, Piet Ost, Alberto Briganti, Valérie Fonteyne, Marco Van Vulpen, Nicolaas Lumen, Martin Spahn & Marc Mareel. (2014) Radiotherapy for renal-cell carcinoma. The Lancet Oncology 15:4, pages e170-e177.
Crossref
Crossref
Daniel Morvan & Aicha Demidem. (2014) Metabolomics and transcriptomics demonstrate severe oxidative stress in both localized chemotherapy-treated and bystander tumors. Biochimica et Biophysica Acta (BBA) - General Subjects 1840:3, pages 1092-1104.
Crossref
Crossref
Liufu Deng, Hua Liang, Byron Burnette, Michael Beckett, Thomas Darga, Ralph R. Weichselbaum & Yang-Xin Fu. (2014) Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice. Journal of Clinical Investigation 124:2, pages 687-695.
Crossref
Crossref
DeeDee Smart & Kevin Camphausen. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
541
551
.
Reid F. Thompson & Amit Maity. 2014. Tumor Microenvironment and Cellular Stress. Tumor Microenvironment and Cellular Stress
147
165
.
Encouse B. Golden, Sandra Demaria, Peter B. Schiff, Abraham Chachoua & Silvia C. Formenti. (2013) An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non–Small Cell Lung Cancer. Cancer Immunology Research 1:6, pages 365-372.
Crossref
Crossref
Shankar Siva, Jason Callahan, Michael P. MacManus, Olga Martin, Rodney J. Hicks & David L. Ball. (2013) Abscopal Effects after Conventional and Stereotactic Lung Irradiation of Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology 8:8, pages e71-e72.
Crossref
Crossref
Anusha Kalbasi, Carl H. June, Naomi Haas & Neha Vapiwala. (2013) Radiation and immunotherapy: a synergistic combination. Journal of Clinical Investigation 123:7, pages 2756-2763.
Crossref
Crossref
K Kono, K Mimura & R Kiessling. (2013) Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation. Cell Death & Disease 4:6, pages e688-e688.
Crossref
Crossref
Silvia C. Formenti & Sandra Demaria. (2013) Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift. JNCI: Journal of the National Cancer Institute 105:4, pages 256-265.
Crossref
Crossref
Michael A. Postow, Margaret K. Callahan, Christopher A. Barker, Yoshiya Yamada, Jianda Yuan, Shigehisa Kitano, Zhenyu Mu, Teresa Rasalan, Matthew Adamow, Erika Ritter, Christine Sedrak, Achim A. Jungbluth, Ramon Chua, Arvin S. Yang, Ruth-Ann Roman, Samuel Rosner, Brenna Benson, James P. Allison, Alexander M. Lesokhin, Sacha Gnjatic & Jedd D. Wolchok. (2012) Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma. New England Journal of Medicine 366:10, pages 925-931.
Crossref
Crossref
DeeDee Smart. 2012. Central Nervous System Metastasis, the Biological Basis and Clinical Considerations. Central Nervous System Metastasis, the Biological Basis and Clinical Considerations
153
186
.
Bin S. Teh, Hiromichi Ishiyama, Angel I. Blanco, Lee E. Ponsky, Simon S. Lo, Bo Xu, E. Brian Butler, Robert J. Amato & Rodney J. Ellis. 2012. Stereotactic Body Radiation Therapy. Stereotactic Body Radiation Therapy
197
209
.
Bertil R. R. Persson, Catrin Bauréus Koch, Gustav Grafström, Crister Ceberg, Per Munck af Rosenschöld, Henrietta Nittby, Bengt Widegren & Leif G. Salford. (2011)
“
Abscopal
” Effect of Radiation Therapy Combined with Immune-Therapy Using IFN-γ Gene Transfected Syngeneic Tumor Cells, in Rats with Bilateral Implanted N29 Tumors
. ISRN Immunology 2011, pages 1-13.
Crossref
Crossref
Angel I. Blanco, Bin S. Teh & Robert J. Amato. (2011) Role of Radiation Therapy in the Management of Renal Cell Cancer. Cancers 3:4, pages 4010-4023.
Crossref
Crossref
Johnny Kao, Eric C. Ko, Samuel Eisenstein, Andrew G. Sikora, Shibo Fu & Shu-hsia Chen. (2011) Targeting immune suppressing myeloid-derived suppressor cells in oncology. Critical Reviews in Oncology/Hematology 77:1, pages 12-19.
Crossref
Crossref
Charles G. Drake. 2011. Molecular Determinants of Radiation Response. Molecular Determinants of Radiation Response
251
263
.
M. Zahidunnabi Dewan, Ashley E. Galloway, Noriko Kawashima, J. Keith Dewyngaert, James S. Babb, Silvia C. Formenti & Sandra Demaria. (2009) Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody. Clinical Cancer Research 15:17, pages 5379-5388.
Crossref
Crossref
Christiane Geiger, Elfriede Nößner, Bernhard Frankenberger, Christine S. Falk, Heike Pohla & Dolores J. Schendel. (2009) Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma. Journal of Molecular Medicine 87:6, pages 595-612.
Crossref
Crossref
Bernhard Frankenberger, Elfriede Noessner & Dolores J. Schendel. (2007) Immune suppression in renal cell carcinoma. Seminars in Cancer Biology 17:4, pages 330-343.
Crossref
Crossref